Dalvinder S. Mandair - Publications

Pancreatic neuroendocrine tumors in patients with tuberous sclerosis: a multicenter study and systematic review.

Journal: Journal of the Endocrine Society

Published: July 29, 2026

Impact of peptide receptor radionuclide therapy (PRRT) on the quality of life in patients with neuroendocrine tumours.

Journal: Journal of neuroendocrinology

Published: March 24, 2026

Management Strategies and Outcomes for Type 1 Gastric Neuroendocrine Tumors Measuring More Than 1 cm.

Journal: Clinical and translational gastroenterology

Published: March 19, 2026

The indolent nature of type 1 gastric neuroendocrine tumors under 1 cm.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: July 05, 2025

68Ga-DOTA-TATE PET/CT improves accuracy and guides management in multiple endocrine neoplasia type 1 (MEN-1) patients with suspected duodeno-pancreatic neuroendocrine tumours.

Journal: Endocrine oncology (Bristol, England)

Published: June 07, 2025

Unravelling mesenteric fibrosis in small intestinal neuroendocrine tumours and implications for clinical management.

Journal: Endocrine-related cancer

Published: April 10, 2025

Endoscopic submucosal dissection for gastric neuroendocrine neoplasms: A multicenter retrospective study.

Journal: Journal of neuroendocrinology

Published: March 31, 2025

177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in metastatic phaeochromocytomas and paragangliomas (mPPGL): a single centre retrospective analysis of experience at an ENETS Centre of Excellence.

Journal: Endocrine oncology (Bristol, England)

Published: February 22, 2025

Octreotide infusion pump in patients with functional neuroendocrine tumors and refractory hormonal syndrome.

Journal: Endocrine oncology (Bristol, England)

Published: February 14, 2025

Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomas.

Journal: Endocrine oncology (Bristol, England)

Published: December 22, 2024

Telotristat ethyl affects tumour-fibroblast crosstalk in small intestinal neuroendocrine tumours.

Journal: Journal of neuroendocrinology

Published: October 08, 2024

Neuroendocrine tumours and pregnancy: Real-world data from an European Neuroendocrine Tumour Centre of Excellence.

Journal: Journal of neuroendocrinology

Published: June 10, 2024